Trends in GLP-1 Receptor Agonist and SGLT2-Inhibitor Utilization and Expenditure Between 2017–2023: Demographic, Income, and Insurance Associations

Journal of General Internal Medicine 2026 Open access

Read full text

Authors: Molly Jacobs, Qianqian Fang, Charles Ellis

DOI: 10.1007/s11606-026-10408-4

Cited by: 1

References: 35

Fields of Study & Subjects

Diabetes Treatment and Management Pharmaceutical studies and practices Bariatric Surgery and Outcomes

References 35